P Gautret, M Million, PA Jarrot… - Expert review of …, 2020 - Taylor & Francis
Introduction: COVID-19 presents benign forms in young patients who frequently present with anosmia. Infants are rarely infected, while severe forms occur in patients over 65 years of …
A Pradelle, S Mainbourg, S Provencher, E Massy… - 2024 - Elsevier
Following publication, the Journal was made aware of readers' debate about this article. The Journal received a number of Letters to the Editor and correspondence from readers. The …
Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing respiratory tract infection, which can induce respiratory failure and multiple organ …
COVID-19 is a serious disease that has infected more than 40 million people. Beside significant mortality, the SARS-CoV-2 infection causes considerable and sustained …
BJ Langford, M So, V Leung, S Raybardhan… - Clinical Microbiology …, 2022 - Elsevier
Background The prevalence of bacterial infection in patients with COVID-19 is low, however, empiric antibiotic use is high. Risk stratification may be needed to minimize unnecessary …
K Crothers, R DeFaccio, J Tate… - European …, 2022 - publications.ersnet.org
Background Dexamethasone decreases mortality in coronavirus disease 2019 (COVID-19) patients on intensive respiratory support (IRS) but is of uncertain benefit if less severely ill …
Importance Communication and adoption of modern study design and analytical techniques is of high importance for the improvement of clinical research from observational data …
N Toroghi, L Abbasian, A Nourian… - Pharmacological …, 2022 - Springer
Background and objectives Corticosteroids are commonly used in the treatment of hospitalized patients with COVID-19. The goals of the present study were to compare the …